Endo International plc: Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

Only ready-to-use (RTU) liquid format of bivalirudin expected to begin shipping in summer 2023RTU bivalirudin injection does not require reconstitution, dilution or mixing, which helps increase

Related Keywords

Dublin ,Ireland ,New Jersey ,United States ,Canada ,Canadian ,Scott Sims ,Gewinn Nur ,Pharmaceuticals Inc ,Exchange Commission ,Endo Ventures ,Linkedin ,Corporate Development ,Injectable Solutions Generics At Endo ,Prnewswire Endo International ,Endo Ventures Limited ,Par Sterile Products ,Senior Vice President ,General Manager ,Injectable Solutions ,Brian Cooney ,Private Securities Litigation Reform Act ,Bankruptcy Code ,Annual Report ,Quarterly Reports ,Kendo ,Nternational ,Nnounces ,Agreement ,Paia ,Pharmaceuticals ,Istribute ,Bivalirudin ,Injection ,Ready ,Vials ,